CLINICAL_TRIALS
withdrawal
· 2022-09-16
Clinical Trial Update: Nitrous Oxide for Pain Management During IUD Insertion in Nulliparous Adolescent Women [Phase 2, Phase 3]
Summary
A Phase 2/3 clinical trial evaluating nitrous oxide for pain management during IUD insertion in nulliparous adolescent women was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Children's Hospital | Conditions: Contraceptive Devices, Long-Acting Reversible Contraception | Phase 2, Phase 3 | Status: WITHDRAWN